• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一名因重症 COVID-19 肺炎而难以脱机的患者中,根据抗原检测结果指导使用瑞德西韦进行晚期治疗。

Late Administration of Remdesivir, Guided by Antigen Test Results, in a Patient Experiencing Difficulty Weaning From the Ventilator Due to Severe COVID-19 Pneumonia.

作者信息

Mataichi Keisuke, Yoshida Takuo

机构信息

Division of Intensive Care, Department of Emergency and Disaster Medicine, Kashiwa Hospital, The Jikei University School of Medicine, Tokyo, JPN.

出版信息

Cureus. 2025 Jul 31;17(7):e89181. doi: 10.7759/cureus.89181. eCollection 2025 Jul.

DOI:10.7759/cureus.89181
PMID:40896071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12398666/
Abstract

A 70-year-old woman with a history of malignant lymphoma (in remission) and systemic sclerosis required mechanical ventilation because of severe coronavirus disease 2019 pneumonia. Despite the administration of broad-spectrum antibiotics, antifungal agents, and corticosteroids, respiratory failure persisted, and a tracheostomy was performed on hospital day 17. Ventilator weaning remained difficult up to hospital day 30 and persistent detection of the severe acute respiratory syndrome coronavirus 2 antigen prompted initiation of remdesivir. Treatment was continued until the antigen became undetectable, after which successful ventilator weaning was achieved. This case suggests an association between prolonged antigen presence and sustained respiratory failure.

摘要

一名70岁女性,有恶性淋巴瘤病史(处于缓解期)和系统性硬化症,因2019冠状病毒病重症肺炎需要机械通气。尽管使用了广谱抗生素、抗真菌药物和皮质类固醇,但呼吸衰竭仍持续存在,并于住院第17天行气管切开术。直到住院第30天,呼吸机撤机仍很困难,严重急性呼吸综合征冠状病毒2抗原的持续检测促使开始使用瑞德西韦。治疗持续至抗原检测不到,此后成功实现了呼吸机撤机。该病例提示抗原长期存在与持续呼吸衰竭之间存在关联。

相似文献

1
Late Administration of Remdesivir, Guided by Antigen Test Results, in a Patient Experiencing Difficulty Weaning From the Ventilator Due to Severe COVID-19 Pneumonia.在一名因重症 COVID-19 肺炎而难以脱机的患者中,根据抗原检测结果指导使用瑞德西韦进行晚期治疗。
Cureus. 2025 Jul 31;17(7):e89181. doi: 10.7759/cureus.89181. eCollection 2025 Jul.
2
Early versus late tracheostomy in critically ill COVID-19 patients.危重症 COVID-19 患者的早期与晚期气管切开术。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD015532. doi: 10.1002/14651858.CD015532.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Pressure support versus T-tube for weaning from mechanical ventilation in adults.成人机械通气撤机时压力支持与T管的比较
Cochrane Database Syst Rev. 2014 May 27;2014(5):CD006056. doi: 10.1002/14651858.CD006056.pub2.
5
Remdesivir for the treatment of COVID-19.瑞德西韦治疗 COVID-19。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2.
6
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.体外二氧化碳清除治疗急性低氧性呼吸衰竭:REST随机对照试验
Health Technol Assess. 2025 Jul;29(33):1-16. doi: 10.3310/GJDM0320.
7
Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure.无创正压通气作为呼吸衰竭成年插管患者的撤机策略。
Cochrane Database Syst Rev. 2013 Dec 9;2013(12):CD004127. doi: 10.1002/14651858.CD004127.pub3.
8
Systemic corticosteroids for the treatment of COVID-19.全身性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Aug 16;8(8):CD014963. doi: 10.1002/14651858.CD014963.
9
Early versus late tracheostomy in people with multiple trauma.多发伤患者早期与晚期气管切开术的比较
Cochrane Database Syst Rev. 2025 Aug 6;8(8):CD015932. doi: 10.1002/14651858.CD015932.pub2.
10
Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation.用于机械通气的危重症患者拔管或撤机的咳嗽增强技术。
Cochrane Database Syst Rev. 2017 Jan 11;1(1):CD011833. doi: 10.1002/14651858.CD011833.pub2.

本文引用的文献

1
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons Learned.美国国立卫生研究院 COVID-19 治疗指南专家组:观点与经验教训。
Ann Intern Med. 2024 Nov;177(11):1547-1557. doi: 10.7326/ANNALS-24-00464. Epub 2024 Oct 1.
2
SARS-CoV-2 viral load is linked to remdesivir efficacy in severe Covid-19 admitted to intensive care.严重 COVID-19 患者在重症监护病房中,SARS-CoV-2 病毒载量与瑞德西韦疗效相关。
Sci Rep. 2024 Sep 6;14(1):20825. doi: 10.1038/s41598-024-71588-9.
3
Remdesivir for the treatment of COVID-19.
瑞德西韦治疗 COVID-19。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014962. doi: 10.1002/14651858.CD014962.pub2.
4
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia.普里替定成功挽救一名既往接受抗 CD20 单克隆抗体介导的 B 细胞耗竭及慢性淋巴细胞白血病治疗的患者,该患者出现持续性病毒 SARS-CoV-2 复制。
J Hematol Oncol. 2022 Jan 10;15(1):4. doi: 10.1186/s13045-021-01220-0.
5
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.医护人员接种两剂灭活病毒疫苗后的免疫原性:有和无既往 COVID-19 感染的前瞻性观察研究。
J Med Virol. 2022 Jan;94(1):279-286. doi: 10.1002/jmv.27316. Epub 2021 Sep 10.
6
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.《拯救脓毒症运动:成人 ICU 中 2019 年冠状病毒病(COVID-19)管理指南》:第一版更新。
Crit Care Med. 2021 Mar 1;49(3):e219-e234. doi: 10.1097/CCM.0000000000004899.
7
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.超敏序列分析血浆中 SARS-CoV-2 抗原和抗体,以了解重症 COVID-19 患者的疾病进展。
Clin Chem. 2020 Dec 1;66(12):1562-1572. doi: 10.1093/clinchem/hvaa213.
8
Structures and distributions of SARS-CoV-2 spike proteins on intact virions.完整病毒上 SARS-CoV-2 刺突蛋白的结构和分布。
Nature. 2020 Dec;588(7838):498-502. doi: 10.1038/s41586-020-2665-2. Epub 2020 Aug 17.
9
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
10
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.对 SARS-CoV-2 基因组、结构、进化、发病机制和治疗方法的深入了解:结构基因组学方法。
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165878. doi: 10.1016/j.bbadis.2020.165878. Epub 2020 Jun 13.